Sea Change Silicides is commercializing the first bioactive glass implant coating for titanium implants.

30-60% of failures occur due to poor bone fusion or bacterial infection, necessitating medical coatings, which currently have drawbacks: synthetic bone coatings (hydroxyapatite) improve bone fusion, without antibacterial properties; ion implantation/polymer coatings can be antibacterial, without bone fusion.

Our new titanium implant coating technology uses bioactive glass, which has not yet been commercialized. Prior studies show bioactive glasses are antibacterial and reduce healing time by 6 times over hydroxyapatite. Bioactive glasses are already FDA approved for use as wound dressings and putties for bone regeneration, but their use as coatings has remained an elusive chemical problem that Sea Change has solved.

The bioactive glass coated implants completely coat the implants, and will have reduced instances of failure, shorter recovery times, enhanced lifetime, and lower cost as compared to competitors.

MEDIA HIGHLIGHTS:

• “Bright New Idea” Award winner, 2025 Wisconsin Governor’s Business Plan Competition
• Sea-Change Silicides aims to revolutionize medical implants
• These 5 Wisconsin tech start-ups won state recognition for their business plans
• UW-Whitewater chemistry professor earns UW Innovation Grant
• UW-Whitewater chemistry student helps land U.S. patent

FOR MORE INFORMATION:

Steven N. Girard, Ph.D.
(262) 472-1096
sea.change.silicides@gmail.com